Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sipai Health Technology Co's Enterprise Value is €36.3 Mil.
Sipai Health Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil. Therefore, Sipai Health Technology Co's EV-to-FCF for today is 739.84.
The historical rank and industry rank for Sipai Health Technology Co's EV-to-FCF or its related term are showing as below:
FRA:AX1'
s EV-to-FCF Range Over the Past 10 Years
Min: -42.56 Med: -12.25 Max: 7518.57
Current: 365.77
During the past 7 years, the highest EV-to-FCF of Sipai Health Technology Co was 7518.57. The lowest was -42.56. And the median was -12.25.
FRA:AX1's EV-to-FCF is ranked worse than 95.59% of 68
companies
in the Medical Distribution industry
Industry Median: 16.065
vs FRA:AX1: 365.77
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sipai Health Technology Co (FRA:AX1) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sipai Health Technology Co's PE Ratio (TTM) for today is calculated as:
Sipai Health Technology Co's share price for today is €0.139.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.025.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sipai Health Technology Co EV-to-FCF Related Terms
Sipai Health Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sipai Health Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's EV-to-FCF falls into.
Sipai Health Technology Co's current Enterprise Value is €36.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co (FRA:AX1) has a EV-to-FCF of 739.84 as of Aug. 20, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sipai Health Technology Co and its competitors. According to the industry distribution chart, Sipai Health Technology Co ranks #65 out of 68 companies in the Medical Distribution industry, placing it in the top 95.6%.
Is Sipai Health Technology Co's EV-to-FCF too high?
Sipai Health Technology Co's current EV-to-FCF is 739.84. The Medical Distribution industry median EV-to-FCF is 16.07. Sipai Health Technology Co's value of 739.84 is 4505.3% above this industry median. Based on the distribution chart, Sipai Health Technology Co ranks #65 out of 68 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sipai Health Technology Co has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sipai Health Technology Co ranks #65 out of 68 companies for EV-to-FCF. This places Sipai Health Technology Co in the lower half of its industry. The industry median EV-to-FCF is 16.07. Sipai Health Technology Co's value of 739.84 is 4505.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.07, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sipai Health Technology Co's current EV-to-FCF of 739.84 is 4505.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sipai Health Technology Co and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sipai Health Technology Co's current EV-to-FCF is 739.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Sipai Health Technology Co (FRA:AX1) has a current EV-to-FCF of 739.84. The stock's GF Value™ is €0.22, compared to a current price of €0.14 — trading 36.8% below its estimated fair value. The current EV-to-FCF is 739.84 and 4505.3% above the Medical Distribution industry median of 16.07. Sipai Health Technology Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sipai Health Technology Co (FRA:AX1), the current EV-to-FCF is 739.84 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (FRA:AX1) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of €0.14 is trading 36.8% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:AX1:
EV-to-FCF: 739.84
GF Value™: €0.22 vs. price of €0.14 (36.8% below fair value)
Industry Position: 4505.3% above the Medical Distribution median (#65 of 68)
No single metric tells the full story. See the FRA:AX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score
Get the complete analysis for FRA:AX1
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AX1 has been successfully added to your 
